1st Oct 2026 07:00
1 October 2026
EDX Medical Group plc
("EDX Medical" or the "Company")
Investor Presentation Via Investor Meet Company
CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, is pleased to announce that Professor Sir Chris Evans, Chief Scientific Officer, will provide a live presentation relevant to existing and potential shareholders via the Investor Meet Company platform on Wednesday 14 October 2026 at 14:30 BST.
The presentation, which will be an introduction to EDX Medical and its corporate screening service, is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet EDX Medical Group plc via:
https://www.investormeetcompany.com/edx-medical-group-plc/register-investor
Investors who already follow EDX Medical Group plc on the Investor Meet Company platform will automatically be invited.
For enquiries, please contact:
EDX Medical Group plc | |
Dr Mike Hudson (Chief Executive Officer) | +44 (0)7812 345 301 |
Canaccord Genuity Limited (Nominated Adviser and Broker) | |
Stuart Andrews | +44 (0) 20 7523 8318 |
Media House International | |
Ramsay Smith | +44 (0)7788 414856 |
Gary McQueen | +44 (0)7834 694609 |
IFC Advisory (Investor Relations) | |
Graham Herring Tim Metcalfe | +44 (0) 203 934 6630 |
About EDX Medical Group plc
The EDX Medical Group plc is listed on the AIM market (TIDM: EDX). The Company develops and supplies class-leading clinical diagnostics products and services.
EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson. The Company operates its own laboratory facilities in Cambridge UK, and has strategic product and technology partnerships with leading life sciences and healthcare organisations. Products and services are available to healthcare providers and individuals, and the Company also offers an employee health screening programme to employers.
By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost effectively improve the early detection and characterisation of disease to enable personalised treatment. Early disease detection and personal treatment optimisation is considered to be the most impactful way of improving patient outcomes.
www.edxmedical.com
Related Shares:
Edx Medical Grp